The list below shows The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.
- ANIMATE - A phase II study testing a targeted drug called nivolumab
Suitable for patients with lymphoma which has come back after previous treatment - AVENuE - A phase II trial of avelumab for untreated advanced classical Hodgkin lymphoma.
Suitable for patients with classical Hodgkin lymphoma who have not yet received treatment
With special thanks to the following: